Anti-CCL2 (Carlumab)-VcMMAE is an antibody-drug conjugate (ADC) composed of the human-derived anti-CCL2 antibody Carlumab, linked with valine-citrulline (vc) and tubulin inhibitor MMAE. The toxic moiety and linker in the ADC are McMMAE. Anti-CCL2 (Carlumab)-VcMMAE can induce apoptosis and is utilized in cancer research.